Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey
- 363 Downloads
Background Drug-related problems (DRPs) interfere with patient optimal therapeutic outcomes and may be associated with higher morbidity, mortality and healthcare expenditures. Objective This study aimed to identify DRPs and their causes in a Turkish hospital. Setting Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Internal Medicine Ward, Istanbul, Turkey. Method Cross-sectional study included a total of 100 patients. Patient demographics, medications, and history were evaluated. Data regarding recent medications were analyzed by two clinical pharmacists and an Internal Medicine physician. The DRPs were identified via V7.0 PCNE classification. Lexicomp® was used to assess the drug–drug interactions. UpToDate® recommendations and national guidelines were applied in the assessment of compliance with approved medication procedures. Main outcome measures Number and causes of the potential DRPs. Results At least one potential DRP was seen in 80% of the patients and 163 potential DRPs were identified (average = 1.6 DRPs/patient). The most common causes of DRPs were errors in drug selection (44.78%), dose selection (27.61%) and medication procedures (21.47%). There were significant correlations (p < 0.05) between DRPs and age (r = 0.4), number of drugs used (r = 0.32), duration of hospitalization (r = 0.25), renal impairment (r = − 0.34) and inflammation (r = 0.31). Conclusion The majority of the patients had DRPs. Patients with renal impairment, inflammation, polypharmacy or an extended hospital stay had a much higher chance of developing DRPs.
KeywordsDose selection Drug-related problem Medication procedure Renal impairment Turkey
The authors are grateful to Meltem Breen and Tayf Alqozbakr for their continuous support.
The authors have no funding to declare.
Conflicts of interest
The authors have no conflicts of interest to declare.
- 1.Adusumilli PK, Adepu R. Drug related problems: an overview of various classification systems. Asian J Pharm Clin Res. 2014;7:7–10.Google Scholar
- 4.Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Dicp Ann Pharmac. 1990;24:1093–7.Google Scholar
- 7.Committee C. Third consensus of granada in drug related problems (DRP) and negative outcomes associated with medication (NOM). Ars Pharm. 2007;48:5–17.Google Scholar
- 17.http://www.pcne.org/upload/files/12_PCNE_classification_V1.pdf. Accessed 11 July 2017.
- 18.http://0210e5a7q.y.https.www.uptodate.com.proxy2.marmara-elibrary.com/contents/search. Accessed 11 July 2017.
- 19.https://online.lexi.com/lco/action/interact. Accessed 11 July 2017.
- 21.https://reference.medscape.com/drug-interactionchecker. Accessed 11 July 2017.
- 27.Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;4:CD003614.Google Scholar
- 33.Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;1(44 Suppl 2):S27–72.CrossRefGoogle Scholar
- 35.http://www.who.int/patientsafety/implementation/solutions/high5s/High5_InterimReport.pdf. Accessed 30 Oct 2017.
- 38.Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacother J Hum Pharmacol Drug Ther. 1996;16:701–7.Google Scholar